Valneva Financial Statements From 2010 to 2025
| INRLF Stock | USD 4.20 0.07 1.64% |
Check Valneva SE financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Valneva SE's main balance sheet or income statement drivers, such as , as well as many indicators such as . Valneva financial statements analysis is a perfect complement when working with Valneva SE Valuation or Volatility modules.
Valneva |
Valneva SE Company Profit Margin Analysis
Valneva SE's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Valneva SE Profit Margin | 0.17 % |
Most of Valneva SE's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Valneva SE is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, Valneva SE has a Profit Margin of 0.1674%. This is 101.49% lower than that of the Healthcare sector and 100.73% lower than that of the Biotechnology industry. The profit margin for all United States stocks is 113.18% lower than that of the firm.
Valneva SE Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Valneva SE's current stock value. Our valuation model uses many indicators to compare Valneva SE value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Valneva SE competition to find correlations between indicators driving Valneva SE's intrinsic value. More Info.Valneva SE is rated below average in return on equity category among its peers. It is rated fourth overall in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Valneva SE's earnings, one of the primary drivers of an investment's value.About Valneva SE Financial Statements
Valneva SE stakeholders use historical fundamental indicators, such as Valneva SE's revenue or net income, to determine how well the company is positioned to perform in the future. Although Valneva SE investors may analyze each financial statement separately, they are all interrelated. For example, changes in Valneva SE's assets and liabilities are reflected in the revenues and expenses on Valneva SE's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Valneva SE. Please read more on our technical analysis and fundamental analysis pages.
Valneva SE, a specialty vaccine company, focuses on the development and commercialization of prophylactic vaccines for infectious diseases with unmet needs. The company was founded in 1998 and is headquartered in Saint-Herblain, France. Valneva Se is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Other Information on Investing in Valneva Pink Sheet
Valneva SE financial ratios help investors to determine whether Valneva Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Valneva with respect to the benefits of owning Valneva SE security.